• 2059 Citations
20082021
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2003Residency, Royal College of Physicians, Ireland
2009Fellowship, University of Texas Health Science Center, San Antonio
2009Fellowship, Royal College of Physicians, Ireland

Education/Academic qualification

PhD, National University of Ireland

… → 2009

MBBChBAO, National University of Ireland

… → 2000

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
TNF-Related Apoptosis-Inducing Ligand Receptors Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2017 2021

Research Output 2008 2018

3 Citations

A phase ii study of pelareorep (REOLYSIN®) in combination with gemcitabine for patients with advanced pancreatic adenocarcinoma

Mahalingam, D., Goel, S., Aparo, S., Arora, S. P., Noronha, N., Tran, H., Chakrabarty, R., Selvaggi, G., Gutierrez, A., Coffey, M., Nawrocki, S. T., Nuovo, G. & Mita, M. M., Jun 1 2018, In : Cancers. 10, 6, 160.

Research output: Contribution to journalArticle

gemcitabine
Adenocarcinoma
Oncolytic Virotherapy
Mammalian orthoreovirus 3
Survival Rate

Case report of prostate ductal adenocarcinoma presenting with hematuria

Pawlowski, J., Swanson, G. P., Mahalingam, D. & Ha, C. S., Jul 1 2018, In : Urology Case Reports. 19, p. 63-64 2 p.

Research output: Contribution to journalArticle

Hematuria
Prostate
Adenocarcinoma
1 Citations

Immunotherapy in colorectal cancer: For the select few or all?

Arora, S. P. & Mahalingam, D., Feb 1 2018, In : Journal of Gastrointestinal Oncology. 9, 1, p. 170-179 10 p.

Research output: Contribution to journalReview article

Immunotherapy
Colorectal Neoplasms
Microsatellite Instability
Therapeutics
4 Citations

Immunotherapy in pancreatic adenocarcinoma - Overcoming barriers to response

Rosenberg, A. & Mahalingam, D., Feb 1 2018, In : Journal of Gastrointestinal Oncology. 9, 1, p. 143-159 17 p.

Research output: Contribution to journalReview article

Immunotherapy
Adenocarcinoma
Oncolytic Virotherapy
Cancer Vaccines
Tumor Microenvironment

Left Versus Right: Does Location Matter for Refractory Metastatic Colorectal Cancer Patients in Phase 1 Clinical Trials?

Arora, S. P., Ketchum, N. S., Michalek, J., Gelfond, J. & Mahalingam, D., Sep 1 2018, In : Journal of Gastrointestinal Cancer. 49, 3, p. 283-287 5 p.

Research output: Contribution to journalArticle

Clinical Trials, Phase I
Colorectal Neoplasms
Survival
Vascular Endothelial Growth Factor A
Disease-Free Survival